| Feature | Specification |
|---|---|
| Application | Newborn Screening |
If not diagnosed and treated within the newborn period, it can lead to diarrhea, dehydration, jaundice, hepatic failure, hypoglycemia, cataracts, developmental retardation, and death within a few weeks. Treatment of the disease consists of withdrawal of all foods containing lactose and galactose from the diet.
GSP Neonatal GALT - the first automated GALT assay
The GSP Neonatal GALT assay is used as an aid in screening newborns for classic galactosemia caused by GALT deficiency using the GSP™ instrument.
| Application |
Newborn Screening
|
|---|---|
| Brand |
GSP®
|
| Detection Modality |
Enzymatic
|
| Disorders |
Galactosemia
|
| Instrument Compatibility |
GSP
|
| Quantity |
1152 tests
|
| Regulatory Status |
CE-IVD marked
|
| Sample Type |
Dried blood spots
|
| Technology |
Enzymatic
|
| Unit Size |
12 plates
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.